secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000950170-24-056928
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Q1 2024 revenue up 2% YoY; net loss narrows to $2.4M from $9.4M
-----------------------------------------------------------------------

- Product revenue $1.255M (+2% YoY); fifth consecutive quarter with >30% gross margin.
- Loss from continuing ops improved 21% to $3.064M; lowest in 6 years.
- Net loss $2.423M ($1.78/share) vs $9.384M ($10.86/share) in Q1 2023, helped by absence of PIPE valuation loss.
- GoodWheat in 3,500+ stores; Zola added ~200 stores in Q1, set to ship to ~1,300 more in Q2.
- Cash & short-term investments $8.5M; operating cash burn $3.21M in quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024056928/0000950170-24-056928-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024056928/rkda-20240509.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-056928

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer